Survival after Locoregional Treatments for Hepatocellular Carcinoma: A Cohort Study in Real-World Patients

Table 2

Effectiveness of locoregional treatment on overall survival in Cox proportional hazard model adjusted by propensity score.

Model	HR (95% CI)	𝑃
RFA versus PEI; (𝑛=47+239)	1.11 (0.79–1.57)	0.53
Surgery versus RFA/PEI; (𝑛=34+255)	0.95 (0.64–1.41)	0.79
TAE/TACE versus RFA/PEI; (𝑛=80+287)	0.88 (0.66–1.17)	0.38

PEI: percutaneous ethanol injection, RFA radiofrequency ablation, TACE/TAE: transarterial embolization with (TACE) or without (TAE) chemotherapy.